PROMIS NEUROSCIENCES INC. - Common Shares (PMN)
CUSIP: 74346M406
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 8,977,479
- Total 13F shares
- 8,473,099
- Share change
- -852,887
- Total reported value
- $4,101,148
- Price per share
- $0.48
- Number of holders
- 19
- Value change
- -$540,895
- Number of buys
- 7
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 74346M406?
CUSIP 74346M406 identifies PMN - PROMIS NEUROSCIENCES INC. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74346M406:
Top shareholders of PMN - PROMIS NEUROSCIENCES INC. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Michael S. Gordon |
13D/G
|
— |
9%
|
4,886,108
|
$2,363,899 | $0 | 30 Jun 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
29%
|
2,645,128
|
$1,839,687 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
26%
|
2,334,826
|
$1,623,871 | — | 31 Mar 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
21%
|
1,929,297
|
$1,341,826 | — | 31 Mar 2025 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
17%
|
1,484,699
|
$1,032,608 | — | 31 Mar 2025 | |
| Altium Capital Management LLC |
13F
|
Company |
6.4%
|
574,248
|
$399,389 | — | 31 Mar 2025 | |
| Madge K. Shafmaster |
3/4/5
|
Director |
—
mixed-class rows
|
228,333
mixed-class rows
|
$270,916 | — | 12 Jun 2025 | |
| Gail M. Farfel |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
108,384
mixed-class rows
|
$256,091 | — | 23 Aug 2023 | |
| Allostery Investments LP |
13F
|
Company |
2.6%
|
233,703
|
$165,158 | — | 31 Mar 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.34%
|
30,366
|
$21,460 | — | 31 Mar 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.29%
|
26,042
|
$18,112 | — | 31 Mar 2025 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.21%
|
18,583
|
$12,924 | — | 31 Mar 2025 | |
| HEIGHTS CAPITAL MANAGEMENT, INC |
13F
|
Company |
0.2%
|
18,267
|
$12,909 | — | 31 Mar 2025 | |
| Gavin T. Malenfant |
3/4/5
|
Chief Operating Officer, Director |
—
mixed-class rows
|
17,820
mixed-class rows
|
$12,342 | — | 26 Oct 2023 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.14%
|
12,122
|
$8,407 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
5,487
|
$4,000 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
1,666
|
$1,158 | — | 31 Mar 2025 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
133
|
$94 | — | 31 Mar 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
88
|
$60 | — | 31 Mar 2025 | |
| Abound Wealth Management |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2025 | |
| Josh Mandel-Brehm |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Jun 2025 | |
| William W. Wyman |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 12 Jun 2025 | |
| Daniel E. Geffken |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
2,500
|
— | — | 26 Oct 2023 |
Institutional Holders of PROMIS NEUROSCIENCES INC. - Common Shares (PMN) as of Q2 2025
As of 30 Jun 2025,
PROMIS NEUROSCIENCES INC. - Common Shares (PMN) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,473,099 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, ARMISTICE CAPITAL, LLC, SPHERA FUNDS MANAGEMENT LTD., Ally Bridge Group (NY) LLC, Allostery Investments LP, CITADEL ADVISORS LLC, Graypoint LLC, Kingsview Wealth Management, LLC, BANK OF MONTREAL /CAN/, and Fiduciary Trust Co.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
17
Q2 2025 holders
19
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.